{"hands_on_practices": [{"introduction": "A crucial first step in analyzing experimental results is to quantify the magnitude of the observed effect. While a $p$-value addresses statistical significance, the effect size speaks to the practical or clinical importance. This exercise [@problem_id:5022328] focuses on calculating a standardized mean difference, a widely used measure of effect size. You will also apply a necessary small-sample correction to obtain a more accurate estimate, a critical consideration in the context of early-phase translational studies where sample sizes are often limited.", "problem": "A first-in-human translational study evaluates the anti-inflammatory effect of a monoclonal antibody by measuring log-transformed changes in circulating tumor necrosis factor-alpha concentration, quantified by enzyme-linked immunosorbent assay (ELISA). Participants are randomized to treatment or placebo. Let group $A$ denote treatment and group $B$ denote placebo. The change in log-concentration from baseline to $24$ hours is assumed approximately normally distributed within each group and the population variances are assumed equal across groups due to matched assay conditions.\n\nThe sample sizes and summary statistics are as follows: group $A$ has $n_A = 11$ participants with sample mean change $\\bar{x}_A = -0.52$ and sample standard deviation $s_A = 0.34$; group $B$ has $n_B = 9$ participants with sample mean change $\\bar{x}_B = -0.12$ and sample standard deviation $s_B = 0.29$.\n\nDefine the standardized mean difference as the difference of group means scaled by the (unknown) common population standard deviation. In small samples, its natural sample-based estimator exhibits finite-sample bias. Compute the small-sample bias-corrected standardized mean difference for the treatment effect, using the pooled sample standard deviation and the conventional small-sample correction for the standardized mean difference. Express the final answer as a single real number. Round your answer to four significant figures and provide it as a dimensionless quantity.", "solution": "The problem statement has been validated and is deemed valid. It is scientifically grounded, well-posed, and contains all necessary information to compute the requested quantity. The problem asks for the calculation of the small-sample bias-corrected standardized mean difference, a well-defined statistical measure of effect size often referred to as Hedges' $g$.\n\nThe calculation proceeds in three main steps. First, we compute the pooled sample standard deviation, which is the best estimate of the common population standard deviation under the assumption of equal variances. Second, we compute the uncorrected standardized mean difference, also known as Cohen's $d$. Finally, we apply the conventional small-sample bias-correction factor to obtain the final result.\n\nThe provided data are:\nFor group $A$ (treatment): sample size $n_A = 11$, sample mean $\\bar{x}_A = -0.52$, and sample standard deviation $s_A = 0.34$.\nFor group $B$ (placebo): sample size $n_B = 9$, sample mean $\\bar{x}_B = -0.12$, and sample standard deviation $s_B = 0.29$.\n\nStep 1: Calculate the pooled sample standard deviation, $s_p$.\nThe formula for the pooled variance, $s_p^2$, is the weighted average of the two sample variances, with weights determined by their degrees of freedom ($n_A-1$ and $n_B-1$).\nThe total degrees of freedom for the estimate is $m = n_A + n_B - 2$.\n\n$$ s_p = \\sqrt{\\frac{(n_A - 1)s_A^2 + (n_B - 1)s_B^2}{n_A + n_B - 2}} $$\n\nSubstituting the given values:\n$$ n_A - 1 = 11 - 1 = 10 $$\n$$ n_B - 1 = 9 - 1 = 8 $$\n$$ n_A + n_B - 2 = 11 + 9 - 2 = 18 $$\n$$ s_p^2 = \\frac{(10)(0.34)^2 + (8)(0.29)^2}{18} $$\n$$ s_p^2 = \\frac{(10)(0.1156) + (8)(0.0841)}{18} $$\n$$ s_p^2 = \\frac{1.156 + 0.6728}{18} = \\frac{1.8288}{18} = 0.1016 $$\n$$ s_p = \\sqrt{0.1016} \\approx 0.3187475 $$\n\nStep 2: Calculate the uncorrected standardized mean difference (Cohen's $d$).\nThis is the difference in sample means divided by the pooled sample standard deviation.\n\n$$ d = \\frac{\\bar{x}_A - \\bar{x}_B}{s_p} $$\n\nSubstituting the values:\n$$ d = \\frac{-0.52 - (-0.12)}{0.3187475} = \\frac{-0.40}{0.3187475} \\approx -1.25492 $$\n\nStep 3: Calculate the bias-corrected standardized mean difference (Hedges' $g$).\nThe estimator $d$ is known to be upwardly biased in small samples. Hedges proposed a correction factor, $J$, which provides an approximately unbiased estimate. The correction factor is a function of the total degrees of freedom, $m = 18$. The conventional approximation for this factor is:\n\n$$ J(m) \\approx 1 - \\frac{3}{4m - 1} $$\n\nSubstituting $m=18$:\n$$ J(18) \\approx 1 - \\frac{3}{4(18) - 1} = 1 - \\frac{3}{72 - 1} = 1 - \\frac{3}{71} $$\n$$ J(18) \\approx 1 - 0.0422535 \\approx 0.9577465 $$\n\nThe bias-corrected standardized mean difference, $g$, is the product of the correction factor and Cohen's $d$.\n\n$$ g = J(m) \\times d $$\n\nSubstituting the calculated values:\n$$ g \\approx 0.9577465 \\times (-1.25492) \\approx -1.201883 $$\n\nThe problem requires the answer to be rounded to four significant figures. The calculated value is $-1.201883$. Rounding to four significant figures yields $-1.202$. The negative sign indicates that the treatment group ($A$) had a larger decrease in the log-transformed TNF-alpha concentration compared to the placebo group ($B$), which is consistent with the desired anti-inflammatory effect. The result is a dimensionless quantity as it is a ratio of means to a standard deviation.", "answer": "$$\\boxed{-1.202}$$", "id": "5022328"}, {"introduction": "After quantifying an effect, we often wish to test the statistical evidence against the null hypothesis. This practice [@problem_id:5022334] moves beyond push-button statistical software to reveal the fundamental logic behind a $p$-value. By calculating an exact $p$-value for a nonparametric test from combinatorial first principles, you will build the null distribution by hand, providing a deep understanding of what this ubiquitous measure truly represents, especially in situations where assumptions of normality are not met.", "problem": "A window-of-opportunity translational medicine study investigates whether a first-in-class kinase inhibitor acutely increases the phosphorylation ratio of a target pathway in tumor biopsies obtained immediately before and after a single therapeutic dose. Because the sample is small and the distribution of within-subject changes is unknown, a nonparametric paired analysis is required. For each subject, let the paired difference be $d_i = \\text{post}_i - \\text{pre}_i$, and assume the distribution of $d_i$ under the null hypothesis is continuous and symmetric about $0$. The pre- and post-dose phosphorylation ratios for $6$ subjects are:\n\nSubject $1$: pre $2.3$, post $2.8$; Subject $2$: pre $2.1$, post $1.8$; Subject $3$: pre $3.0$, post $4.2$; Subject $4$: pre $2.5$, post $3.3$; Subject $5$: pre $1.9$, post $1.5$; Subject $6$: pre $2.7$, post $3.6$.\n\nStarting only from the core definitions of the Wilcoxon signed-rank test, compute the exact two-sided $p$-value for testing the null hypothesis that the median paired difference is $0$. Your derivation must proceed from the assumptions stated above, treat all absolute differences with their exact integer ranks (no ties are present), and use combinatorial counting of sign allocations to obtain the exact null distribution of the signed-rank statistic. Express the final $p$-value as a reduced fraction. Do not report a confidence interval (CI) or effect size in your final answer. Your final answer must be a single number. If you choose to provide a decimal as an intermediate step, do not round in the final reported fraction.", "solution": "The problem statement has been validated and is deemed valid. It is scientifically grounded, well-posed, objective, and internally consistent. It presents a standard biostatistical problem based on realistic data from translational medicine and requests a calculation using a well-defined, appropriate statistical method. The problem provides all necessary information and contains no contradictions.\n\nThe task is to compute the exact two-sided $p$-value for a Wilcoxon signed-rank test on a paired dataset of size $n=6$. The null hypothesis, $H_0$, is that the median of the paired differences is $0$. The analysis is based on the assumption that the distribution of the paired differences is continuous and symmetric about $0$.\n\nFirst, we calculate the paired differences, $d_i = \\text{post}_i - \\text{pre}_i$, for each of the $n=6$ subjects.\n- Subject $1$: $d_1 = 2.8 - 2.3 = 0.5$\n- Subject $2$: $d_2 = 1.8 - 2.1 = -0.3$\n- Subject $3$: $d_3 = 4.2 - 3.0 = 1.2$\n- Subject $4$: $d_4 = 3.3 - 2.5 = 0.8$\n- Subject $5$: $d_5 = 1.5 - 1.9 = -0.4$\n- Subject $6$: $d_6 = 3.6 - 2.7 = 0.9$\n\nNext, we take the absolute values of these non-zero differences, $|d_i|$, and rank them from smallest ($1$) to largest ($6$).\n- $|d_2| = 0.3 \\implies \\text{Rank} = 1$\n- $|d_5| = 0.4 \\implies \\text{Rank} = 2$\n- $|d_1| = 0.5 \\implies \\text{Rank} = 3$\n- $|d_4| = 0.8 \\implies \\text{Rank} = 4$\n- $|d_6| = 0.9 \\implies \\text{Rank} = 5$\n- $|d_3| = 1.2 \\implies \\text{Rank} = 6$\nThere are no ties in the absolute differences, as stated in the problem. The set of ranks is $\\{1, 2, 3, 4, 5, 6\\}$.\n\nThe Wilcoxon signed-rank test statistic is based on the sum of the ranks corresponding to the positive or negative differences. Let $W^+$ be the sum of ranks of the positive differences and $W^-$ be the sum of ranks of the negative differences.\n- The differences $d_1, d_3, d_4, d_6$ are positive. Their corresponding ranks are $3, 6, 4, 5$.\n- The differences $d_2, d_5$ are negative. Their corresponding ranks are $1, 2$.\n\nWe calculate the observed values of $W^+$ and $W^-$:\n$$ W^+ = 3 + 6 + 4 + 5 = 18 $$\n$$ W^- = 1 + 2 = 3 $$\nAs a check, the sum of the statistics must equal the total sum of ranks: $W^+ + W^- = 18 + 3 = 21$.\nThe total sum of ranks is given by $\\frac{n(n+1)}{2} = \\frac{6(6+1)}{2} = \\frac{42}{2} = 21$. The calculation is consistent.\n\nFor a two-sided test, the test statistic, let's call it $W$, is the minimum of $W^+$ and $W^-$.\n$$ w_{obs} = \\min(W^+, W^-) = \\min(18, 3) = 3 $$\n\nUnder the null hypothesis ($H_0$), each difference $d_i$ has a $50\\%$ chance of being positive or negative, independently of its rank. Therefore, any of the $n=6$ ranks has a probability of $\\frac{1}{2}$ of being positive and $\\frac{1}{2}$ of being negative. With $6$ ranks, there are $2^6 = 64$ possible, equally likely combinations of signed ranks.\n\nThe two-sided $p$-value is the probability of observing a test statistic $W$ as extreme as or more extreme than $w_{obs}$. This is $P(W \\le w_{obs})$.\nThe event $W \\le 3$ is equivalent to the event $(W^+ \\le 3 \\text{ or } W^- \\le 3)$.\nThe events $W^+ \\le 3$ and $W^- \\le 3$ are mutually exclusive. If $W^+ \\le 3$, then $W^- = 21 - W^+ \\ge 21 - 3 = 18$, so $W^-$ cannot be less than or equal to $3$.\nThus, the $p$-value is $P(W^+ \\le 3) + P(W^- \\le 3)$.\nThe null distribution of $W^+$ is symmetric to that of $W^-$. Therefore, $P(W^+ \\le k) = P(W^- \\le k)$ for any $k$.\nThe $p$-value is $2 \\times P(W^+ \\le 3)$.\n\nWe need to count the number of ways to choose a subset of the ranks $\\{1, 2, 3, 4, 5, 6\\}$ whose sum is less than or equal to $3$. Let this count be $N_{extreme, 1-tail}$.\nThe possible sums for $W^+$ are:\n- Sum = $0$: This corresponds to the empty set of ranks (all differences are negative). There is $1$ way.\n- Sum = $1$: The set of one rank $\\{1\\}$. There is $1$ way.\n- Sum = $2$: The set of one rank $\\{2\\}$. There is $1$ way.\n- Sum = $3$: The set of one rank $\\{3\\}$, or the set of two ranks $\\{1, 2\\}$. There are $2$ ways.\nThe total number of ways to obtain a $W^+$ sum of $0, 1, 2,$ or $3$ is $N_{extreme, 1-tail} = 1 + 1 + 1 + 2 = 5$.\n\nThe one-sided probability is $P(W^+ \\le 3) = \\frac{N_{extreme, 1-tail}}{\\text{Total combinations}} = \\frac{5}{2^6} = \\frac{5}{64}$.\nThe two-sided $p$-value is:\n$$ p = 2 \\times P(W^+ \\le 3) = 2 \\times \\frac{5}{64} = \\frac{10}{64} $$\nThis fraction must be reduced to its simplest form.\n$$ p = \\frac{10 \\div 2}{64 \\div 2} = \\frac{5}{32} $$\nThe exact two-sided $p$-value for the Wilcoxon signed-rank test is $\\frac{5}{32}$.", "answer": "$$\\boxed{\\frac{5}{32}}$$", "id": "5022334"}, {"introduction": "The insights gained from pilot studies are most powerful when used to design more definitive future research. This final practice [@problem_id:5022351] synthesizes all the core concepts: a clinically meaningful effect size, desired statistical power ($1-\\beta$), and a controlled Type I error rate ($\\alpha$). You will perform a blinded sample size re-estimation, a sophisticated and efficient method used in modern clinical trial design to ensure a study is adequately powered based on updated information.", "problem": "A biomarker-guided randomized study in translational medicine compares a novel therapy to standard care for patients with a refractory inflammatory condition. The primary endpoint is the log-transformed change in plasma concentration of a protein marker over a fixed time window, denoted by $Y$, which is assumed to be normally distributed with a common variance across arms. The planned analysis is a two-sample comparison of means with equal allocation. Let the treatment arm have mean $\\mu_{T}$, the control arm have mean $\\mu_{C}$, and the common variance be $\\sigma^{2}$. The clinical objective is to detect superiority defined by a clinically meaningful difference $\\delta = \\mu_{T} - \\mu_{C} = 0.3$ in log units, using a two-sided hypothesis test at significance level $\\alpha = 0.05$ with desired power $1 - \\beta = 0.8$.\n\nA blinded internal pilot was conducted with $m_{T} = 20$ patients in the treatment arm and $m_{C} = 20$ patients in the control arm. The unbiased sample variances from the two arms are $s_{T}^{2} = 0.09$ and $s_{C}^{2} = 0.12$. Under a blinded sample size re-estimation procedure that updates the variance while keeping $\\delta$, $\\alpha$, and $\\beta$ fixed, derive from first principles the total sample size required to achieve the target power for the two-sided test. Express the re-estimated total sample size as a single closed-form analytic expression involving the inverse cumulative distribution function of the standard normal distribution, $\\Phi^{-1}(\\cdot)$. Do not numerically approximate or round; provide the exact analytic expression only.", "solution": "We start from the core definitions of hypothesis testing for two independent normal samples with a common variance. Let $Y_{T,1}, \\dots, Y_{T,n}$ be independent and identically distributed as $\\mathcal{N}(\\mu_{T}, \\sigma^{2})$ in the treatment arm, and $Y_{C,1}, \\dots, Y_{C,n}$ be independent and identically distributed as $\\mathcal{N}(\\mu_{C}, \\sigma^{2})$ in the control arm, with equal per-arm sample size $n$. The parameter of interest is the mean difference $\\Delta = \\mu_{T} - \\mu_{C}$. We test the two-sided null hypothesis $H_{0}: \\Delta = 0$ against the alternative $H_{1}: \\Delta \\neq 0$, with Type I error $\\alpha$ and desired power $1 - \\beta$ to detect a clinically meaningful effect $\\delta  0$.\n\nDefine the difference in sample means $D = \\bar{Y}_{T} - \\bar{Y}_{C}$. By the properties of independent normal samples, under $H_{0}$, $D$ has mean $0$ and variance $\\operatorname{Var}(D) = \\sigma^{2}\\left(\\frac{1}{n} + \\frac{1}{n}\\right) = \\frac{2\\sigma^{2}}{n}$. The standardized test statistic\n$$\nZ = \\frac{D}{\\sigma \\sqrt{2/n}}\n$$\nhas, by the Central Limit Theorem (CLT) and exact normality here, an approximate standard normal distribution under $H_{0}$ with mean $0$ and variance $1$. The two-sided rejection region at significance level $\\alpha$ is $\\{|Z|  z_{1-\\alpha/2}\\}$, where $z_{1-\\alpha/2}$ is the $(1-\\alpha/2)$ quantile of the standard normal distribution.\n\nUnder the alternative hypothesis with true difference $\\Delta = \\delta  0$, the distribution of $Z$ is normal with mean\n$$\n\\mu_{A} = \\frac{\\mathbb{E}[D]}{\\sigma \\sqrt{2/n}} = \\frac{\\delta}{\\sigma \\sqrt{2/n}} = \\frac{\\delta \\sqrt{n}}{\\sigma \\sqrt{2}},\n$$\nand variance $1$. The power is the probability of rejecting $H_{0}$ under $H_{1}$:\n$$\n\\text{Power} = \\mathbb{P}\\left(|Z|  z_{1-\\alpha/2} \\,\\middle|\\, \\mu = \\mu_{A}\\right) = \\mathbb{P}\\left(Z  z_{1-\\alpha/2}\\right) + \\mathbb{P}\\left(Z  -z_{1-\\alpha/2}\\right).\n$$\nFor a positive mean shift $\\mu_{A}  0$, the dominant contribution to power is $\\mathbb{P}(Z  z_{1-\\alpha/2})$, and the standard planning approximation sets\n$$\n\\mathbb{P}\\left(Z  z_{1-\\alpha/2}\\right) = 1 - \\Phi\\left(z_{1-\\alpha/2} - \\mu_{A}\\right) = 1 - \\beta,\n$$\nwhich implies\n$$\n\\Phi\\left(z_{1-\\alpha/2} - \\mu_{A}\\right) = \\beta \\quad \\Rightarrow \\quad z_{1-\\alpha/2} - \\mu_{A} = z_{\\beta} = - z_{1-\\beta}.\n$$\nTherefore,\n$$\n\\mu_{A} = z_{1-\\alpha/2} + z_{1-\\beta}.\n$$\nSubstituting $\\mu_{A} = \\delta \\sqrt{n}/(\\sigma \\sqrt{2})$ and solving for $n$ yields the per-arm sample size\n$$\nn = \\frac{2 \\sigma^{2} \\left(z_{1-\\alpha/2} + z_{1-\\beta}\\right)^{2}}{\\delta^{2}}.\n$$\n\nA blinded sample size re-estimation updates $\\sigma^{2}$ with an unbiased pooled variance estimate from the internal pilot, without using any information about the accumulated treatment effect, thereby preserving the Type I error. With $m_{T} = 20$ and $m_{C} = 20$, and unbiased sample variances $s_{T}^{2} = 0.09$ and $s_{C}^{2} = 0.12$, the pooled variance estimator is\n$$\n\\hat{\\sigma}^{2} = \\frac{(m_{T} - 1) s_{T}^{2} + (m_{C} - 1) s_{C}^{2}}{m_{T} + m_{C} - 2} = \\frac{(20 - 1)\\cdot 0.09 + (20 - 1)\\cdot 0.12}{20 + 20 - 2}.\n$$\nCompute the numerator:\n$$\n(19)\\cdot 0.09 + (19)\\cdot 0.12 = 19 \\cdot (0.09 + 0.12) = 19 \\cdot 0.21 = 3.99,\n$$\nand the denominator is $38$. Thus\n$$\n\\hat{\\sigma}^{2} = \\frac{3.99}{38} = 0.105 = \\frac{21}{200}.\n$$\n\nUsing the updated variance in the planning formula with $\\delta = 0.3$ (so $\\delta^{2} = 0.09 = \\frac{9}{100}$), the re-estimated per-arm sample size becomes\n$$\nn_{\\text{new}} = \\frac{2 \\hat{\\sigma}^{2} \\left(z_{1-\\alpha/2} + z_{1-\\beta}\\right)^{2}}{\\delta^{2}} = \\frac{2 \\cdot \\frac{21}{200} \\cdot \\left(z_{1-\\alpha/2} + z_{1-\\beta}\\right)^{2}}{\\frac{9}{100}}.\n$$\nThe total sample size is $N_{\\text{new}} = 2 n_{\\text{new}}$, therefore\n$$\nN_{\\text{new}} = 2 \\cdot \\frac{2 \\cdot \\frac{21}{200} \\cdot \\left(z_{1-\\alpha/2} + z_{1-\\beta}\\right)^{2}}{\\frac{9}{100}} = \\frac{4 \\cdot \\frac{21}{200}}{\\frac{9}{100}} \\cdot \\left(z_{1-\\alpha/2} + z_{1-\\beta}\\right)^{2}.\n$$\nSimplify the scalar factor:\n$$\n\\frac{4 \\cdot \\frac{21}{200}}{\\frac{9}{100}} = 4 \\cdot \\frac{21}{200} \\cdot \\frac{100}{9} = 4 \\cdot \\frac{2100}{1800} = 4 \\cdot \\frac{7}{6} = \\frac{14}{3}.\n$$\nThus,\n$$\nN_{\\text{new}} = \\frac{14}{3} \\left(z_{1-\\alpha/2} + z_{1-\\beta}\\right)^{2}.\n$$\n\nRecognizing that $z_{p} = \\Phi^{-1}(p)$ for the standard normal cumulative distribution function $\\Phi$, and substituting $\\alpha = 0.05$ and $\\beta = 0.2$, we obtain\n$$\nN_{\\text{new}} = \\frac{14}{3} \\left(\\Phi^{-1}(1 - \\alpha/2) + \\Phi^{-1}(1 - \\beta)\\right)^{2} = \\frac{14}{3} \\left(\\Phi^{-1}(0.975) + \\Phi^{-1}(0.8)\\right)^{2}.\n$$\n\nThis expression is the exact closed-form analytic re-estimated total sample size under blinded variance updating, maintaining the planned effect size and error rates. It directly connects hypothesis testing (through the critical values), $p$-values (via the test statisticâ€™s reference distribution), confidence intervals (since the same standard error governs interval width), and effect size (through $\\delta$ and the standardized shift $\\delta/(\\sigma \\sqrt{2/n})$), satisfying the translational medicine design constraints.", "answer": "$$\\boxed{\\frac{14}{3}\\left(\\Phi^{-1}(0.975)+\\Phi^{-1}(0.8)\\right)^{2}}$$", "id": "5022351"}]}